Skip to main content
Top
Published in: Infection 4/2021

Open Access 01-08-2021 | Vaccination | Case Report

Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions

Authors: Ozan E. Eren, Matthias Tonon, Florian Schöberl, Clemens Gießen-Jung, Andreas Moosmann, Alexandra Hollaus, Maximilian Muenchhoff, Konstantinos Dimitriadis

Published in: Infection | Issue 4/2021

Login to get access

Abstract

The case describes the coincidental mRNA vaccination and SARS-CoV-2 infection of a 31-year-old physician addressing the theoretical considerations and recommendations for further actions in such a particular constellation that we will expect more often in the near future.
Literature
2.
go back to reference Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–15.CrossRef Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine. N Engl J Med. 2020;383:2603–15.CrossRef
3.
go back to reference Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–8.CrossRef Long Q-X, Liu B-Z, Deng H-J, Wu G-C, Deng K, Chen Y-K, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26:845–8.CrossRef
4.
go back to reference Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, et al. Profile of immunoglobulin g and igm antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71:2255–8.CrossRef Qu J, Wu C, Li X, Zhang G, Jiang Z, Li X, et al. Profile of immunoglobulin g and igm antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis. 2020;71:2255–8.CrossRef
5.
go back to reference Lu L, Zhang H, Zhan M, Jiang J, Yin H, Dauphars DJ, et al. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? Sci China Life Sci. 2020;63:1833–49.CrossRef Lu L, Zhang H, Zhan M, Jiang J, Yin H, Dauphars DJ, et al. Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development? Sci China Life Sci. 2020;63:1833–49.CrossRef
6.
go back to reference Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. Nature. 2020;586:594–9.CrossRef Sahin U, Muik A, Derhovanessian E, Vogler I, Kranz LM, Vormehr M, et al. COVID-19 vaccine BNT162b1 elicits human antibody and T H 1 T cell responses. Nature. 2020;586:594–9.CrossRef
7.
go back to reference Walsh EE, Robert W. Frenck J, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of two RNA-based COVID-19 vaccine candidates. N Engl J Med. Massachusetts Medical Society; 2020. https://www.nejm.org/doi/https://doi.org/10.1056/NEJMoa2027906. Cited 10 Jan 2021. Walsh EE, Robert W. Frenck J, Falsey AR, Kitchin N, Absalon J, Gurtman A, et al. Safety and Immunogenicity of two RNA-based COVID-19 vaccine candidates. N Engl J Med. Massachusetts Medical Society; 2020. https://​www.​nejm.​org/​doi/​https://​doi.​org/​10.​1056/​NEJMoa2027906. Cited 10 Jan 2021.
8.
go back to reference Martin LK, Hollaus A, Stahuber A, Hübener C, Fraccaroli A, Tischer J, et al. Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B. PLOS Pathog. 2018;14:e1006991.CrossRef Martin LK, Hollaus A, Stahuber A, Hübener C, Fraccaroli A, Tischer J, et al. Cross-sectional analysis of CD8 T cell immunity to human herpesvirus 6B. PLOS Pathog. 2018;14:e1006991.CrossRef
9.
go back to reference Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589–93.CrossRef Mulligan MJ, Lyke KE, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586:589–93.CrossRef
Metadata
Title
Coincidental SARS-CoV-2 infection and mRNA vaccination: a case report addressing the most important clinical questions
Authors
Ozan E. Eren
Matthias Tonon
Florian Schöberl
Clemens Gießen-Jung
Andreas Moosmann
Alexandra Hollaus
Maximilian Muenchhoff
Konstantinos Dimitriadis
Publication date
01-08-2021
Publisher
Springer Berlin Heidelberg
Published in
Infection / Issue 4/2021
Print ISSN: 0300-8126
Electronic ISSN: 1439-0973
DOI
https://doi.org/10.1007/s15010-021-01613-w

Other articles of this Issue 4/2021

Infection 4/2021 Go to the issue